The DOI matches its Crossref record; 297 of the 297 references it cites were found in a registry or an index.
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
Abstract
Aromatase is the enzyme that catalyzes the conversion of androgens to estrogens. Initial studies of its enzymatic activity and function took place in an environment focused on estrogen as a component of the birth control pill. At an early stage, investigators recognized that inhibition of this enzyme could have major practical applications for treatment of hormone-dependent breast cancer, alterations of ovarian and endometrial function, and treatment of benign disorders such as gynecomastia. Two general approaches ultimately led to the development of potent and selective aromatase inhibitors. One targeted the enzyme using analogs of natural steroidal substrates to work out the relationships between structure and function. The other approach initially sought to block adrenal function as a treatment for breast cancer but led to the serendipitous finding that a nonsteroidal P450 steroidogenesis inhibitor, aminoglutethimide, served as a potent but nonselective aromatase inhibitor. Proof of the therapeutic concept of aromatase inhibition involved a variety of studies with aminoglutethimide and the selective steroidal inhibitor, formestane. The requirement for even more potent and selective inhibitors led to intensive molecular studies to identify the structure of aromatase, to development of high-sensitivity estrogen assays, and to "mega" clinical trials of the third-generation aromatase inhibitors, letrozole, anastrozole, and exemestane, which are now in clinical use in breast cancer. During these studies, unexpected findings led investigators to appreciate the important role of estrogens in males as well as in females and in multiple organs, particularly the bone and brain. These studies identified the important regulatory properties of aromatase acting in an autocrine, paracrine, intracrine, neurocrine, and juxtacrine fashion and the organ-specific enhancers and promoters controlling its transcription. The saga of these studies of aromatase and the ultimate utilization of inhibitors as highly effective treatments of breast cancer and for use in reproductive disorders serves as the basis for this first Endocrine Reviews history manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–297 of 297
Aromatase inhibitors ? mechanisms of steroidal inhibitors
Brueggemeier, R. W. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682739 · Cited by 75
SAMOJLIK, E., Santen, R. J., & Worgul, T. J. (1982) · Steroids · doi:10.1016/0039-128x(82)90050-2 · Cited by 75
Self-citationTranscriptional regulation of aromatase in placenta and ovary
Mendelson, C. R., Jiang, B., Shelton, J. M., Richardson, J. A., & Hinshelwood, M. M. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.04.016 · Cited by 73
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
Gibson, L., Dawson, C., Lawrence, D., & Bliss, J. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003370.pub2 · Cited by 73
The effects of aromatase inhibitors and antiestrogens in the nude mouse model
Lü, Q., Yue, W., Wang, J., Liu, Y., Long, B. J., & Brodie, A. M. H. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006004930930 · Cited by 72
Self-citationBellino, F. L., Gilani, S. S. H., Eng, S. S., Osawa, Y., & Duax, W. L. (1976) · Biochemistry · doi:10.1021/bi00666a030 · Cited by 72
Safi, R., Kovacic, A., Gaillard, S. L., Murata, Y., Simpson, E. R., McDonnell, D. P., & Clyne, C. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2792 · Cited by 70
Self-citationRegulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue
Clyne, C. D., Kovacic, A., Speed, C. J., Zhou, J., Pezzi, V., & Simpson, E. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.001 · Cited by 69
Self-citationPostmenopausal advanced breast cancer: Options for therapy after tamoxifen and aromatase inhibitors
Dodwell, D. J., Wardley, A. M., & Johnston, S. R. D. (2006) · The Breast · doi:10.1016/j.breast.2006.01.007 · Cited by 69
Osawa, Y., Yoshida, N., Fronckowiak, M. D., & Kitawaki, J. (1987) · Steroids · doi:10.1016/0039-128x(83)90058-2 · Cited by 69
Demura, M., Martin, R. M., Shozu, M., Sebastian, S., Takayama, K., Hsu, W.-T., Schultz, R. A., Neely, K., Bryant, M., Mendonca, B. B., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm145 · Cited by 69
The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.
Demers, L. M., Melby, J. C., Wilson, T. E., Lipton, A., Harvey, H. A., & Santen, R. J. (1990) · PubMed · Cited by 68
Self-citationUse of aromatase inhibitors to increase final height
Dunkel, L. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.031 · Cited by 68
Stereochemistry of estrogen biosynthesis
Fishman, J., Guzik, H. S., & Dixon, D. (1969) · Biochemistry · doi:10.1021/bi00839a013 · Cited by 67
Santner, S. J., Chen, S., Zhou, D., Korsunsky, Z., Martel, J., & Santen, R. J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90267-z · Cited by 66
Self-citationFatemi, H. M., Al-Turki, H., Papanikolaou, E. G., Kosmas, L., Sutter, P. D., & Devroey, P. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61140-6 · Cited by 66
Marcotte, P. A., & Robinson, C. H. (1982) · Steroids · doi:10.1016/0039-128x(82)90151-9 · Cited by 65
Geisler, J., & Lønning, P. E. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.04.015 · Cited by 65
Hinshelwood, M. M., Liu, Z., Conley, A. J., & Simpson, E. R. (1995) · Biology of Reproduction · doi:10.1095/biolreprod53.5.1151 · Cited by 64
Self-citationDiethylstilbestrol: Recommended Dosages for Different Categories of Breast Cancer Patients
Carter, A. C. (1977) · JAMA · doi:10.1001/jama.1977.03270460065023 · Cited by 64
Sexual partner preference, hypothalamic morphology and aromatase in rams
Roselli, C. E., Larkin, K., Schrunk, J. M., & STORMSHAK, F. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.08.017 · Cited by 63
Harvey, H. A., Santen, R. J., Osterman, J., SAMOJLIK, E., White, D. S., & Lipton, A. (1979) · Cancer · doi:10.1002/1097-0142(197906)43:6<2207::aid-cncr2820430608>3.0.co;2-1 · Cited by 63
Self-citationIngle, J. N., JOHNSON, P. A., Suman, V. J., Gerstner, J. B., Mailliard, J. A., Camoriano, J. K., Gesme, D. H., Loprinzi, C. L., Hatfield, A. K., & Hartmann, L. C. (1997) · Cancer · Cited by 63
Kvinnsland, S., Anker, G. B., Dirix, L. Y., Bonneterre, J. M., Prové, A., Wilking, N. E., Lobelle, J. ‐., Mariani, O., di Salle, E., Polli, A., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00041-1 · Cited by 62
Characterization of stable human aromatase expressed in E. coli
Kagawa, N., Hori, H., Waterman, M. R., & Yoshioka, S. (2004) · Steroids · doi:10.1016/j.steroids.2004.01.002 · Cited by 59
Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast
Bulun, S. E., Sharda, G., Rink, J., Sharma, S., & Simpson, E. R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772611 · Cited by 59
Self-citationFamilial Hyperestrogenism in Both Sexes: Clinical, Hormonal, and Molecular Studies of Two Siblings
Martin, R. M., Lin, C. J., Nishi, M. Y., Billerbeck, A. E. C., Latronico, A. C., Russell, D. W., & Mendonca, B. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021780 · Cited by 59
Callard, G. V., Hoffman, R. A., Petro, Z., & Ryan, K. J. (1979) · Biology of Reproduction · doi:10.1095/biolreprod21.1.33 · Cited by 58
Song, R., Zhang, Z., Mor, G., & Santen, R. J. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1903-2 · Cited by 57
Self-citationDistribution of Aromatase Cytochrome P450 Messenger Ribonucleic Acid in Adult Rhesus Monkey Brains1
Abdelgadir, S. E., Roselli, C. E., Choate, J. V. A., & Resko, J. A. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.4.772 · Cited by 57
Ghosh, S., Lu, Y., Katz, A. J., Hu, Y., & Li, R. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00242.2006 · Cited by 57
Stopping Treatment Can Reverse Acquired Resistance to Letrozole
Sabnis, G. J., Macedo, L. F., Goloubeva, O. G., Schayowitz, A., & Brodie, A. M. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5999 · Cited by 56
Self-citationChakraborty, J., Hopkins, R., & Parke, D. V. W. (1972) · Biochemical Journal · doi:10.1042/bj1300019pb · Cited by 54
The intermediate steps in the biosynthesis of estrogens from androgens
Morato, T., Hayano, M., Dorfman, R. I., & Axelrod, L. R. (1961) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(61)90140-1 · Cited by 54
Klein, K. O., Demers, L. M., Santner, S. J., Baron, J., Cutler, G. B., & Santen, R. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673408 · Cited by 54
Self-citationToda, K., & Shizuta, Y. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17772.x · Cited by 54
Hahn, E. F., & Fishman, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43462-4 · Cited by 52
Selective aromatase inhibition for patients with androgen‐independent prostate carcinoma
Smith, M. R., Kaufman, D., George, D. J., et al. (2002) · Cancer · doi:10.1002/cncr.10844 · Cited by 50
Toda, K., Terashima, M., Mitsuuchi, Y., Yamasaki, Y., Yokoyama, Y., Nojima, S., Ushiro, H., Maeda, T., Yamamoto, Y., Sagara, Y., et al. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81373-0 · Cited by 49
Aromatase and prostate cancer.
Ellem, S. J., & Risbridger, G. P. (2006) · PubMed · Cited by 48
Treatment of Pubertal Gynecomastia with the Specific Aromatase Inhibitor Anastrozole
Riepe, F. G., Baus, I., Wiest, S., Krone, N. P., Sippell, W. G., & Partsch, C. (2004) · Hormone Research in Paediatrics · doi:10.1159/000079882 · Cited by 48
The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects
Trunet, P., Mueller, P., Girard, F., Aupetit, B., Bhatnagar, A. S., Zognbi, F., Ezzet, F., & Ménard, J. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1531483 · Cited by 46
Goss, P. E., Jarman, M., Wilkinson, J. R., et al. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90128-7 · Cited by 45
Bajetta, E., Martinetti, A., Zilembo, N., Pozzi, P., Torre, I. L., Ferrari, L., Seregni, E. C., Longarini, R., Salvucci, G., & Bombardieri, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf083 · Cited by 45
STUDIES ON THE AROMATIZATION OF C‐19 ANDROGENS*
Thompson, E. A., & Siiteri, P. K. (1973) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1973.tb47608.x · Cited by 45
Self-citationChen, S., Ye, J., Kijima, I., Kinoshita, Y., & Zhou, D. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.04.002 · Cited by 44
Huddleston, G. G., Paisley, J. C., & Clancy, A. N. (2006) · Neuroendocrinology · doi:10.1159/000094400 · Cited by 44
Lü, M., Chen, D., Lin, Z., Reierstad, S., Trauernicht, A. M., Boyer, T. G., & Bulun, S. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1364 · Cited by 43
Neurosteroids and the songbird model system
Schlinger, B. A., & London, S. E. (2006) · Journal of Experimental Zoology Part A Comparative Experimental Biology · doi:10.1002/jez.a.303 · Cited by 41
Santen, R. J., Petroni, G. R., Fisch, M. J., Myers, C. E., Theodorescu, D., & Cohen, R. B. (2001) · Cancer · Cited by 40
Self-citationSanten, R. J. (1981) · Breast Cancer Research and Treatment · doi:10.1007/bf01806259 · Cited by 40
Self-citationÆstrogenic Hormone in the Urine of the Stallion
Zondek, B. (1934) · Nature · doi:10.1038/133494a0 · Cited by 40
Overview of the Pharmacology of the Aromatase Inactivator Exemestane
Brueggemeier, R. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016121822916 · Cited by 40
Stuart‐Harris, R., Dowsett, M., D'SOUZA, A., Donaldson, A., Harris, A. L., Jeffcoate, S. L., & Smith, I. E. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01083.x · Cited by 40
Solubilization and partial purification of human placental cytochromes P-450
Pasanen, M., & Pelkonen, O. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)90265-5 · Cited by 39
Intracrine mechanism of estrogen synthesis in breast cancer
Suzuki, T., Moriya, T., Ishida, T., et al. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.09.007 · Cited by 39
Recombinant Cell Ultrasensitive Bioassay for Measurement of Estrogens in Postmenopausal Women
Wang, S., Paris, F., Sultan, C., Song, R. X.-D., Demers, L. M., Sundaram, B., Settlage, J. A., Ohorodnik, S. K., & Santen, R. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0766 · Cited by 39
Self-citationAromatization and 5α-reduction in brain and nonneural tissues of a cyclostome, Petromyzon marinus
Callard, G. V., Petro, Z., & Ryan, K. J. (1980) · General and Comparative Endocrinology · doi:10.1016/0016-6480(80)90181-1 · Cited by 38
Tominaga, T., Adachi, I., Sasaki, Y., Tabei, T., Ikeda, T., Takatsuka, Y., Toi, M., Suwa, T., & Ohashi, Y. (2002) · Annals of Oncology · doi:10.1093/annonc/mdg014 · Cited by 38
Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
Harvey, H. A., Lipton, A., White, D., Santen, R. J., Boucher, A. E., Shafik, A., & Dixon, R. (1982) · PubMed · Cited by 37
Self-citationShenton, K., Dowsett, M., Lü, Q., Brodie, A. M., Sasano, H., Sacks, N. P. M., & Rowlands, M. G. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006033813899 · Cited by 36
Self-citationBoon, W. C., Diepstraten, J., van der Burg, J. M. M., Jones, M. E. E., Simpson, E. R., & van den Buuse, M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.07.004 · Cited by 33
Self-citationDemonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts
Santen, R. J., Martel, J., Hoagland, M. S., Naftolin, F. N., Roa, L., Harada, N., Hafer, L. J., Zaino, R. J., Pauley, R. J., & Santner, S. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006081729828 · Cited by 33
Self-citationGruntmanis, U., & Braunstein, G. D. (2001) · PubMed · Cited by 33
Aromatase in human breast carcinoma.
Perel, E., Blackstein, M. E., & Dw, K. (1982) · PubMed · Cited by 32
Amarneh, B., & Simpson, E. R. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03524-b · Cited by 32
Self-citationRegulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts
Pauley, R. J., Santner, S. J., Tait, L. R., Bright, R. K., & Santen, R. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6345 · Cited by 32
Self-citationCharlier, T. D., Harada, N., Ball, G. F., & Balthazart, J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.023 · Cited by 31
Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells
Yue, W., Wang, J., Li, Y., Fan, P., & Santen, R. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21222 · Cited by 31
Self-citationLocal uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues
Larionov, A. A., Berstein, L. M., & Miller, W. R. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00047-x · Cited by 31
Santen, R. J. (1981) · Clinical Biochemistry · doi:10.1016/s0009-9120(81)90964-4 · Cited by 30
Self-citationBoccardo, F., RUBAGOTTI, A., Aldrighetti, D., Buzzi, F., Cruciani, G., Farris, A., Mustacchi, G., Porpiglia, M., Schieppati, G., & Sismondi, P. (2007) · Cancer · doi:10.1002/cncr.22513 · Cited by 30
Cardiovascular Safety Profiles of Aromatase Inhibitors
Nabholtz, J., & Gligorov, J. (2006) · Drug Safety · doi:10.2165/00002018-200629090-00003 · Cited by 29
Harris, A. L., Dowsett, M., Smith, I. E., & Jeffcoate, S. L. (1984) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(84)90230-x · Cited by 29
Masamura, S., Santner, S. J., & Santen, R. J. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(96)00065-9 · Cited by 28
Self-citationReed, M. J., Beranek, P. A., Ghilchik, M. W., & James, V. H. T. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90151-3 · Cited by 27
Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women
Dowsett, M., Donaldson, K. M., Tsuboi, M., et al. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000113 · Cited by 25
Aromatase inhibitors as adjuvant treatment of breast cancer
Geisler, J., & Lønning, P. E. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.05.005 · Cited by 25
Expression and purification of a recombinant form of human aromatase from Escherichia coli
Zhang, F., Zhou, D., Kao, Y., Ye, J., & Chen, S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01361-8 · Cited by 24
The in vivo mechanisms of origin of estrogen in subjects with trophoblastic tumors
MacDonald, P. C., & Siiteri, P. K. (1966) · Steroids · doi:10.1016/0039-128x(66)90001-8 · Cited by 23
Self-citationShozu, M., Sumitani, H., Murakami, K., Segawa, T., Yang, H.-J., & Inoue, M. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00129-7 · Cited by 23
Trunet, P. F., Bhatnagar, A. S., Chaudri, H. A., & Hornberger, U. (1996) · Acta Oncologica · doi:10.3109/02841869609083962 · Cited by 22
The Continuing Saga of Dehydroepiandrosterone (DHEA)
Siiteri, P. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0852 · Cited by 22
Self-citationPurification and characterization of aromatase from human placenta
Hall, P. F., Chen, S., Nakajin, S., Shinoda, M., & Shively, J. E. (1987) · Steroids · doi:10.1016/0039-128x(83)90060-0 · Cited by 21
Kleeberg, U. R., Dowsett, M., Carrion, R. P., Dodwell, D. J., Vorobiof, D., Aparicio, L. A., & Robertson, J. F. R. (2009) · Oncology · doi:10.1159/000227752 · Cited by 21
Regulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts
Pauley, R. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.837 · Cited by 20
LOW-DOSE AMINOGLUTETHIMIDE AND AROMATASE INHIBITION
Dowsett, M., Jeffcoate, S. L., Santner, S. J., Santen, R. J., Stuart‐Harris, R., & Smith, I. E. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91955-5 · Cited by 19
Self-citationSogon, T., Masamura, S., Hayashi, S., et al. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.104 · Cited by 19
Rose, C. (2003) · American Journal of Clinical Oncology · doi:10.1097/00000421-200308001-00003 · Cited by 19
Aromatase and regulation of bone remodeling
Ribot, C. A., Trémollières, F., & Pouillès, J. M. (2005) · Joint Bone Spine · doi:10.1016/j.jbspin.2005.02.005 · Cited by 16
Concerning the pathway from 19-oxoandrost-4-ene-3,17-dione to estrone
Caspi, E., & Njar, V. C. O. (1987) · Steroids · doi:10.1016/0039-128x(87)90024-9 · Cited by 13
A review of the newer aromatase inhibitors in the management of metastatic breast cancer
Reddy (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00145.x · Cited by 12
Lieberman, S., Ma, S., & He, Y. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.040 · Cited by 9
Oestrogen suppression—lessons from clinical studies
Lønning, P. E. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00051-4 · Cited by 7
Integration of endocrine therapy with targeted agents
Johnston, S. R. D. (2008) · Breast Cancer Research · doi:10.1186/bcr2180 · Cited by 7
SAMOJLIK, E., Santen, R. J., Kirschner, M. A., et al. (1982) · PubMed · Cited by 5
Self-citationLipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
Cited by
Eastell, R., O'Neill, T. W., Hofbauer, L. C., Langdahl, B., Reid, I. R., Gold, D. T., & Cummings, S. R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.69 · Cited by 827
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 790
Kenkre, J., & Bassett, J. (2018) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563218759371 · Cited by 693
Cooke, P. S., Nanjappa, M. K., Ko, C., Prins, G. S., & Hess, R. A. (2017) · Physiological Reviews · doi:10.1152/physrev.00018.2016 · Cited by 466
Hormone Action in the Mammary Gland
Brisken, C., & O'Malley, B. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003178 · Cited by 453
Metadata
- Authors
- Santen, R. J., Brodie, H., Simpson, E. R., Siiteri, P. K., & Brodie, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2009-06-01
- Volume
- 30
- Issue
- 4
- Pages
- 343-375
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2011925462
- Cited by
- 442
- References
- 297
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.